Dr Darrin Disley

Darrin is the former Chief Executive Officer and President of Horizon Discovery Group plc, an internationally recognised life science company that he led from IP to IPO and to being the market leader in gene editing and gene modulation.

As a life scientist, Darrin has been involved in the start-up and growth of numerous business ventures and is an investor in over 40 others.

He has won a number of awards throughout his career, including Business Leader of the Year at the European Life Science Awards (2012), Executive of the Year at the global Scrip Awards (2014), Entrepreneur of the Year at the UK Quoted Company Awards (2014), a lifetime Queens Award for his work in supporting young entrepreneurs and the UK life science industry (2016), Public Life Science Company CEO of the Year at the Biotech and Money Awards (2017)  and Barclays Iconic UK Male Entrepreneur (2017).

In 2018 he was made an Officer of the Order of the British Empire for his services to business, enterprise and healthcare.

Darrin is a Board Member of the Bio Industry Association, an Enterprise Fellow in Chemical Engineering and Biotechnology and an Honorary Fellow in Entrepreneurship of the Cambridge Judge Business School both at the University of Cambridge and an Honorary Visiting Fellow in Environmental and Life Science at the University of Salford. He holds a PhD in Biotechnology from Cambridge University and a DSc (Honoris Causa) from the University of Salford.

Twitter Feed